News
42m
inews.co.uk on MSNHow WeightWatchers won’t be the last company to die thanks to OzempicThe company has filed for chapter 11 bankruptcy in the US to give itself some protection from creditors and time to try and ...
A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.
We expected miracles—what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
In the bankruptcy filing, WeightWatchers' parent company, WW International Inc., said nearly three-quarters of its creditors ...
GLP-1 medications like Ozempic, Wegovy and Mounjaro have gone from obscure diabetes treatments to front-page news thanks to ...
The celebrated actress has lost more than 100Ib after turning to controversial diabetes jab Ozempic - now better known for its impact on tackling obesity ...
Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...
Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...
U.S. trade policy has also heightened investor concerns over the potential impact to Novo Nordisk's key market. U.S. President Trump has threatened to unveil tariffs on pharmaceutical products in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results